McMillian Shakespeare Ltd (ASX: MMS) requested a trading halt over its shares this morning until it made an announcement to the ASX.
What’s Going On With McMillan?
In the ASX announcement, McMillan stated the proposed merger with Eclipx Group Ltd (ASX: ECX) that was first announced in November 2018 is unlikely to proceed.
It cited various issues with Eclipx, but particularly their net profit after tax and amortisation (NPATA) being down 42.4% compared to the first five months of FY18.
Under the proposed merger, Elipx shareholders were to receive 0.1414 MMS shares and $0.46 cash for every Eclipx share, implying a total value of $2.85 per Eclipx share at the time the merger was proposed.
Eclipx has since stated that it believes the merger is unlikely to proceed.
McMillan Shakespeare shares were up 3.3% on the news as shareholders probably feel they dodged a bullet, whereas Elipx shares were hammered as much as 56% down to a low of $0.825.
If you’re looking to dodge bullets in the small caps, keep reading…
NEW! Our #1 ASX ETF of 2019
Exchange-Traded Funds (ETFs) are changing the world of investing. But with so many on the ASX, it's hard to know which ETF will be a top performer in 2019.
Every financial Tom, Dick and Harry seems to 'launching' (read: flogging) an ETF to investors. In our humble opinion, most of them could be a waste of time - and money. Worse, many of them could fail!
Here's the best part: we're willing to release the name and ASX ticker code of the ETF we've identified as our #1 for 2019.
Just click here now to access our free "#1 ETF of 2019" report. No credit card details or payment required.
Disclaimer: Any information contained in this article is limited to general financial/investment advice only. The information has not taken into account your specific needs, goals or objectives, so please consider consulting a licenced and trusted adviser before acting on the information. Please read The Rask Group’s Financial Services Guide (FSG) for more information. This article is authorised by Owen Raszkiewicz of The Rask Group, which is a corporate authorised representative No. 1264179 of Strawman Pty Ltd (ACN: 610 908 211) (AFSL: 501 223).